The EBMT

05/09/2025

Day 1️⃣ of has been fantastic, with plenty of opportunities to share, connect, and expand our knowledge in HCT and cellular therapies. 💡✍️

Before we wrap up the first day, we are looking forward to Alex Rampota's keynote and the Poster Session!

05/09/2025

Good morning from the Faculty of Medicine, University of Barcelona! ☀️ The 10th International Transplant and Cellular Therapy Course is live, and we are ready for an exciting 3-day deep dive into cellular therapies, transplant science, CAR-T, and more.

What are you most excited to learn about? 🧠 Share your favourite moments with us and tag The EBMT and !

04/09/2025

📅 Today is World Leukaemia Day – another important occasion during to raise awareness and support better patient outcomes. 🏥

💡 At EBMT, the Acute Leukaemia Working Party (ALWP) is dedicated to advancing research, improving transplant strategies, and sharing knowledge to improve care for patients with acute leukaemia. Learn more about the ALWP and meet the team: https://ebmt.org/working-parties/acute-leukaemia-working-party-alwp

04/09/2025

September 4 marks World Leukaemia Day 📆

💡 Tune into the latest episode of the Blood Matters - Podcast for Nurses, as hosts Emma Chalmers and Hilda Mekelenkamp explore with Thomas Jezequel the latest advances in paediatric acute leukaemia, including:
🔹 The growing use of CAR T-cell therapy
🔹 Personalised treatment approaches
🔹 Evolving conditioning regimens
… and much more.

🎙️ Listen on Spotify or watch on YouTube ⬇️
🔗 https://www.youtube.com/watch?v=Wxls2ceuIys&list=PLd5j0y9uSMDkVcogIe0aiVNYMpYGCUhkS&index=1

In this episode, Thomas Jezequel shares expert insights into the latest advances in paediatric acute leukaemia, including the growing use of CAR T-cell thera...

01/09/2025

🔴 September is

At EBMT, we join the global effort to increase public understanding of blood cancers and highlight the importance of early diagnosis.

Through collaborative science and clinical expertise, we are committed to advancing research, improving patient outcomes, and driving innovation in the treatment of blood-related disorders.

Let's raise awareness together and support those affected by blood cancers. 🌍

29/08/2025

💡 Graft-versus-host disease remains a key focus for HCT specialists, with ongoing research critical to improving management and understanding.

Lars Klingen Gjærde, Lynn Leppla and Olaf Penack shared their insights on the latest advancements in GvHD at .

Watch the full episode on YouTube, link in the comments. ⬇️

27/08/2025

🆕 We are proud to join the EU-funded EASYGEN consortium together with 17 other institutions across 8 countries to decentralise and accelerate CAR-T cell therapy across Europe. 🌍

🎯 The goal: hospital-based, automated CAR-T manufacturing in just days, boosting access, reducing cost and easing hospital workloads.

🏥 This is a major step toward democratizing breakthrough cancer therapies and delivering innovative, personalised treatments where they are needed most.

🔗 Read more in the recent Press Release:https://www.ebmt.org/sites/default/files/2025-08/EASYGEN_EBMT_press_release_August2025.pdf

25/08/2025

📣 Yesterday marked two years since the launch of the EBMT Registry’s new system – a major milestone in how transplant and cellular therapy data is collected, managed, and shared across Europe and beyond. 📊

In this interview, Per Ljungman reflects on the Registry’s impact and its potential to drive research, clinical innovation, and improve patient care looking forwad. 💬 Watch the full clip on YouTube.

24/08/2025

🎉 Today, the EBMT Registry celebrates its anniversary

In August 2023, the EBMT Registry system went live, improving how transplant and cellular therapy data is collected, managed, and shared across Europe and beyond. 🌐

This progress wouldn’t be possible without the dedication of our community - your contributions make the EBMT Registry a powerful resource driving research and improving patient care.

🔗 Read more: https://www.ebmt.org/ebmt/news/marking-another-anniversary-ebmt-registry

11/08/2025

🌍 What are the biggest barriers to health equity in HCT and cellular therapy?

In this episode, Nada Hamad and Sunil Bhat discuss major challenges and how solutions like haploidentical transplants, graft engineering, and international collaboration can help close the gap.

📺 Discover more ⬇️
https://youtu.be/5PsXBMq0ydU?feature=shared

08/08/2025

🎬 As this year marks the 10th anniversary of the International Transplant and Cellular Therapy Course, we took a look back at where it all began. 📜

Check out the playlist from the inaugural edition in 2016, spot some familiar faces, and see how far we have come together: https://youtube.com/playlist?list=PLd5j0y9uSMDkiGvhtW2ubBZ6dJljHVDC6&feature=shared

📅 Are you joining us for in September to be part of the next chapter? 🚀

01/08/2025

in September will cover core content aligned with the EBMT Exam 2026 syllabus, making it an essential resource for trainees and early-career professionals aiming for certification. ✅

👉 Watch the video to learn more about the EBMT Exam and join us for the 10th International Transplant and Cellular Therapy Course in Barcelona 📆⬇️
🔗 https://youtu.be/y-z4AStyCHI?si=rJdn8FrDALX-_5G_

Learn about the EBMT Exam and its role in advancing medical education in HSCT and cellular therapies. Annalisa Ruggeri, Scientific Council Representative wit...